Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Change in Account Payables (2019 - 2021)

Historic Change in Account Payables for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to -$694000.0.

  • Black Diamond Therapeutics' Change in Account Payables fell 5119.83% to -$694000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.6 million, marking a year-over-year increase of 4677.27%. This contributed to the annual value of $1.7 million for FY2024, which is 18190.95% up from last year.
  • Black Diamond Therapeutics' Change in Account Payables amounted to -$694000.0 in Q4 2021, which was down 5119.83% from $628000.0 recorded in Q3 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Change in Account Payables peaked at $2.9 million during Q3 2020, and registered a low of -$3.8 million during Q2 2020.
  • Moreover, its 3-year median value for Change in Account Payables was $275000.0 (2019), whereas its average is $341000.0.
  • Over the last 5 years, Black Diamond Therapeutics' Change in Account Payables had its largest YoY gain of 453333.33% in 2020, and its largest YoY loss of 125833.33% in 2020.
  • Black Diamond Therapeutics' Change in Account Payables (Quarter) stood at $958000.0 in 2019, then crashed by 147.91% to -$459000.0 in 2020, then plummeted by 51.2% to -$694000.0 in 2021.
  • Its Change in Account Payables was -$694000.0 in Q4 2021, compared to $628000.0 in Q3 2021 and -$356000.0 in Q2 2021.